Literature DB >> 31187185

Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland.

Min-Shu Hsieh1,2, Yung-Ming Jeng1,2, Yi-Hsuan Lee3.   

Abstract

Muscle, intestine, and stomach expression 1 (Mist1) is a transcription factor that functions in the development of granule organisation in serous exocrine cells of the gastrointestinal tract. The aim of this study was to investigate whether Mist1 can be used as a marker for acinic cell carcinoma (AciCC) of the salivary gland. Immunohistochemistry (IHC) was used to analyse Mist1 expression in AciCC (n = 26), secretory carcinoma (SC; n = 18) and 12 other types of salivary gland tumours (n = 99). Strong Mist1 staining was observed in normal serous acinar cells and plasma cells. Mist1 was diffusely expressed in AciCC, with the immunostaining intensity ranging from moderate (4/26) to strong (22/26). Most SC specimens were either negative (7/18) or focally and mildly positive (9/18) for Mist1. Only two SC cases demonstrated a moderate level of Mist1 staining. When moderate-to-strong Mist1 staining was used as the criterion of positivity, all the tested salivary gland tumours other than AciCC were negative for Mist1, except for two cases of SC. Previously cut tissue sections and decalcified specimens exhibited reduced Mist1 immunostaining intensity, which may give false-negative results. In summary, Mist1 is a sensitive marker for serous acinar cells of salivary glands and AciCC, and background non-tumour acinar cells and plasma cells can serve as good internal positive controls.

Entities:  

Keywords:  Acinic cell carcinoma; BHLHA15; Mist1; Salivary gland; Secretory carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31187185     DOI: 10.1007/s00428-019-02600-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  22 in total

1.  Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.

Authors:  Kalyani R Patel; Isaac H Solomon; Samir K El-Mofty; James S Lewis; Rebecca D Chernock
Journal:  Hum Pathol       Date:  2013-09-10       Impact factor: 3.466

2.  Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.

Authors:  Justin A Bishop; Raluca Yonescu; Denise Batista; Shahnaz Begum; David W Eisele; William H Westra
Journal:  Hum Pathol       Date:  2013-06-14       Impact factor: 3.466

3.  Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.

Authors:  Fernanda Viviane Mariano; Camila Andrea Concha Gómez; Juliana de Souza do Nascimento; Harim Tavares Dos Santos; Erika Said Egal; Victor Angelo Martins Montalli; Pablo Agustin Vargas; Oslei Paes de Almeida; Albina Altemani
Journal:  Head Neck Pathol       Date:  2016-05-13

4.  The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland.

Authors:  Simon Andreasen; Sushama Varma; Nicholas Barasch; Lester D R Thompson; Markku Miettinen; Lisa Rooper; Edward B Stelow; Tina K Agander; Raja R Seethala; Simion I Chiosea; Preben Homøe; Irene Wessel; Stine R Larsen; Daiva Erentaite; Justin A Bishop; Benedicte P Ulhøi; Katalin Kiss; Linea C Melchior; Jonathan R Pollack; Robert B West
Journal:  Am J Surg Pathol       Date:  2019-04       Impact factor: 6.394

5.  MIST1-a novel marker of plasmacytic differentiation.

Authors:  Cecilia C S Yeung; Jason C Mills; Anjum Hassan; Frederike H Kreisel; TuDung T Nguyen; John L Frater
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-12

6.  SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.

Authors:  Rie Ohtomo; Taisuke Mori; Shinsuke Shibata; Koji Tsuta; Akiko M Maeshima; Chihiro Akazawa; Yukio Watabe; Kazufumi Honda; Tesshi Yamada; Seiichi Yoshimoto; Masao Asai; Hideyuki Okano; Yae Kanai; Hitoshi Tsuda
Journal:  Mod Pathol       Date:  2013-04-05       Impact factor: 7.842

7.  Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases.

Authors:  Alena Skalova; Tomas Vanecek; Petr Martinek; Ilan Weinreb; Todd M Stevens; Roderick H W Simpson; Martin Hyrcza; Niels J Rupp; Martina Baneckova; Michael Michal; David Slouka; Tomas Svoboda; Alena Metelkova; Arghavan Etebarian; Jaroslav Pavelka; Steven J Potts; Jason Christiansen; Petr Steiner; Michal Michal
Journal:  Am J Surg Pathol       Date:  2018-02       Impact factor: 6.394

8.  Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes.

Authors:  Alena Skálová; Radek Sima; Tomas Vanecek; Susan Muller; Marie Korabecna; Jana Nemcova; Goran Elmberger; Ilmo Leivo; Fabricio Passador-Santos; Jiri Walter; Milena Rousarova; Kristina Jedlickova; Romuald Curik; Marie Geierova; Michal Michal
Journal:  Am J Surg Pathol       Date:  2009-08       Impact factor: 6.394

9.  The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity.

Authors:  C L Pin; J M Rukstalis; C Johnson; S F Konieczny
Journal:  J Cell Biol       Date:  2001-11-05       Impact factor: 10.539

10.  Sox10 Regulates Plasticity of Epithelial Progenitors toward Secretory Units of Exocrine Glands.

Authors:  Harleen K Athwal; George Murphy; Ellis Tibbs; Ashley Cornett; Emily Hill; Kenji Yeoh; Elsa Berenstein; Matthew P Hoffman; Isabelle M A Lombaert
Journal:  Stem Cell Reports       Date:  2019-01-31       Impact factor: 7.765

View more
  5 in total

1.  Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancer.

Authors:  Jingjing Dai; Abdusemer Reyimu; Ao Sun; Zaxi Duoji; Wubi Zhou; Song Liang; Suxia Hu; Weijie Dai; Xiaoguang Xu
Journal:  Sci Rep       Date:  2022-05-14       Impact factor: 4.996

Review 2.  Salivary gland function, development, and regeneration.

Authors:  Alejandro M Chibly; Marit H Aure; Vaishali N Patel; Matthew P Hoffman
Journal:  Physiol Rev       Date:  2022-03-28       Impact factor: 46.500

3.  Expression Analysis of MIST1 and EMT Markers in Primary Tumor Samples Points to MIST1 as a Biomarker of Cervical Cancer.

Authors:  Wei Wang; Xin Xie; Zhangjian Zhou; Hao Zhang
Journal:  Int J Gen Med       Date:  2021-04-14

4.  DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling.

Authors:  Hongzhong Zhou; Yiqun Du; Xiafei Wei; Chunli Song; Jianning Song; Nanson Xu; Weihong Huang; Lichan Chen; Fuwen Yao; Duanming Du; Chuanghua Qiu; Lihong Zhong; Yuchen Liu; Dayong Gu; Jin Wang; Yong Xu
Journal:  Theranostics       Date:  2022-08-15       Impact factor: 11.600

5.  Mist1 Inhibits Epithelial-Mesenchymal Transition in Gastric Adenocarcinoma via Downregulating the Wnt/β-catenin Pathway.

Authors:  Xin Xie; Zhangjian Zhou; Yongchun Song; Xin Zhang; Chengxue Dang; Hao Zhang
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.